By continuing to use the site you agree to our Privacy & Cookies policy

Leading SSRI 'may cause potentially fatal heart rhythm problems'

The most commonly used antidepressant in Britain may pose a small risk of potentially fatal heart rhythm complications.

Citalopram is currently prescribed to a million Britons. But new research published in the British Medical Journal (BMJ) says it raises the likelihood of having a problem known as Long QT Syndrome.

This is when electrical drives that control the heart take longer to ‘recharge’ between beats.

The findings show that some, but not all, antidepressants known as Selective Serotonin Re-uptake Inhibitors (SSRIs), including citalopram and escitalopram, can spark this heart rhythm disturbance.

UK and US regulators have already warned doctors to be particularly cautious about which patients they prescribe these medicines to.

The new research backs up recent advice from the US Food & Drug Administration (FDA) about the drug citalopram and suggest some other antidepressants may have similar effects.

The US researchers, whose findings were published in the BMJ, investigated the risk in a big, diverse clinical population following the FDA’s warnings.

They tracked 38,397 adult New England patients who had an ECG after an antidepressant or methadone prescription between February 1990 and August 2011.

Several other risk elements were factored in, such as age, race, sex, history of depression, heart attack, high blood pressure, heart rhythm problems and pre-existing conditions. Methadone was included in the tests as it is also known to contribute to a longer QT interval.

Researchers discovered a small but substantially longer QT interval for SSRIs citalopram and escitalopram as well as for methadone and the tricyclic antidepressant amitriptyline. This effect got bigger at higher doses, suggesting a dose-response association.

Authors stressed that “nearly 20% of patients treated with these antidepressants who undertook electrocardiography had QT intervals which would be considered abnormal” although they added that the clinical significance of this is unknown. But a shorter QT interval was seen for the drug bupropion, even at higher doses.

Other standard antidepressants were not associated with a longer QT interval and further analyses did not significantly alter the results.

June Davison, senior cardiac nurse at the British Heart Foundation, said: “Having a long QT interval can potentially increase the risk of a serious abnormal heart rhythm.

“However, as these abnormal rhythms are very rare, the potential benefits in treating depression would exceed the risk for most patients.”

Readers' comments (6)

  • tinkerbell

    unfortunately most of our elderly folk in care homes are on this particular antidepressant and probably most of those with depression of other ages. Has it something to do with it being the cheapest to px?

    Unsuitable or offensive?

  • will these drugs be withdrawn?
    it is sad that so many people don't, or are unable to question, medication they are prescribed and in some cases such as the elderly administered.

    Unsuitable or offensive?

  • tinkerbell

    citalopram rebranded as escitalopram by same drug company as it patent ran out on citalopram it seems. Probably got shed loads of the stuff to off load. Money, money, money.

    So long as as drug doesn't kill the rats in the first few weeks of a trial it is apparently considered 'safe'.

    Unsuitable or offensive?

  • Tinkerbell

    we'll soon find out if shed loads of dead rats are discovered!

    Unsuitable or offensive?

  • tinkerbell

    at least they died supposedly 'happy'.

    Unsuitable or offensive?

  • My mother takes Citalopram for anxiety/stress/depression related to being main carers for her dementia diagnosied husband. It does have a positive effect on her. I know this because on several occasions she has forgotten to get her repeat prescription and her mood changes as a result of not taking her tablets.

    Unsuitable or offensive?

Have your say

You must sign in to make a comment.

Related Jobs

Sign in to see the latest jobs relevant to you!

newsletterpromo